ZYBERNO
Stock Report
Updated Aug 31, 2026

Zomedica Corp. (ZOMDF)

Healthcare • OTC

$0.08

Professional Investment Analysis

ZYBERNO SCORE
Is it a great business? Is it getting better?
30.0/100
WEAK BUSINESS
Zomedica Corp. (ZOMDF) scores 30/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.
📊 How is the Zyberno Score calculated? +
VALUATION SIGNAL
N/A (Requires more data)
Requires fair value calculation and current price data
💰 How is Margin of Safety calculated? +
📈 How is Brina Gap calculated? +

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-16.7%)
Debt-to-Equity (Solvency Risk):EXCELLENT (0.03x)
Operating Margin (Operational Efficiency):CRITICAL (-56.3%)
Return on Capital (Capital Efficiency):CRITICAL (-15.3%)
📊 Valuation Trilogy
Three interconnected metrics for complete valuation analysis
Click any metric for full methodology and detailed analysis
Zyberno's Verdict

Zomedica Corp. (ZOMDF) stock report — Zyberno Score 30/100 (WEAK BUSINESS). Full financial analysis on Zyberno.

Over the trailing twelve months, ZOMDF generated -$16.61M in Owner Earnings. Capital was deployed as follows: $347.00K invested in capital expenditures. Reinvestment rate: 355.1%.

DIVISION I: EXECUTIVE SUMMARY
A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.08
Market Cap:$80.36M

Valuation Multiples (3)

P/B Ratio:0.75x
P/S Ratio:2.18x
Peg Ratio:-999.00x

Enterprise Metrics (1)

Enterprise Value:$74.99M

Price Action & Momentum (3)

Momentum Percentile:95 / 100
% of 52-Week High:51.9%
B. Profitability Assessment

Return Metrics (5)

ROA:-15.2%
Reinvestment Rate:355.1%
Fundamental Growth Rate (g):-54.2%

Margin Analysis (3)

Operating Margin Ttm:-56.3%
Net Margin Ttm:-51.4%
Ebitda Margin:-23.6%

TTM Performance (3)

Gross Margin Ttm:65.4%
Operating Margin Ttm:-56.3%
Net Margin Ttm:-51.4%

Yield Metrics (2)

Earnings Yield:-$102.27
Dividend Yield:0.0%
C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

EPS Surprise vs Expected:100.0%
Latest Earnings Filed:2026-05-06

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):16.3%
D. Financial Stability

Liquidity Ratios (3)

Current Ratio:6.43x
Quick Ratio:5.76x
Cash Ratio:0.80x

Leverage Analysis (3)

Debt To Equity Ttm:0.03x
Debt-to-Equity Ratio:0.03x
Debt To Ebitda:-999.00x

Coverage Ratios (1)

Times Interest Earned:-999.00

Capital Structure (4)

Working Capital:48,891,000.00
Cash And Cash Equivalents:7,194,000.00
Long Term Debt:$1.11M
Net Debt:-$5.36M
DIVISION II: FINANCIAL STATEMENTS ANALYSIS
A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $36.88M
Linear Growth: 16.3%
📊 Click to view full ZOMDF Revenue analysis & methodology →
Cost Of Revenue Ttm:$12.75M

Profitability Breakdown (2)

Gross profit TTM: $24.13M
Linear Growth: 13.5%
📊 Click to view full ZOMDF Gross Profit analysis & methodology →
-$20.75M

Bottom Line Performance (3)

-$18.95M
Income Before Tax:-$19.12M
Ebitda Ttm:-8,704,000.00

Operating Expenses (5)

Operating Expenses:0.00
R And D Expense:5,651,000.00
Sga Expense:22,864,000.00
Income Tax Expense:-$168.00K
Interest Expense:0.00

Expense Ratios (3)

R And D To Revenue Percentage:59.4%
Sga To Revenue Percentage:240.4%
Ebitda Margin:-23.6%
B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$118.15M
Current Assets:$57.89M
Ppe Net:20,039,000.00
Goodwill:0.00
Intangible Assets:$37.37M

Liability Structure (4)

Total Liabilities:10,863,000.00
Current Liabilities:9,002,000.00
Long Term Debt:$1.11M
Short Term Debt:$718.00K

Equity & Capital (3)

Equity:$107.28M
Retained Earnings:-$308.07M
Common Stock:380,973,000.00

Working Capital Items (3)

Accounts Receivable:5,669,000.00
Inventory:6,050,000.00
Accounts Payable:6,141,000.00

Special Items (2)

Contract Liabilities:657,000.00
Stock Based Compensation:643,000.00
C. Cash Flow Analysis

Operating Activities (2)

-$16.26M-$16.61M

Investment Activities (2)

Investing Cash Flow:$5.62M
Capital Expenditures Ttm:347,000.00

Financing Activities (3)

Financing Cash Flow:$0.00
Dividends Paid Ttm:0.00
Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00
Long Term Debt Issuance:$0.00
Long Term Debt Repayments:$0.00

Non-Cash Items (1)

Depreciation Amortization Ttm:12,049,000.00
DIVISION III: OPERATIONAL METRICS
A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-0.08
-$0.09
Earnings Per Share Ttm:-$0.02

Revenue & Cash Per Share (2)

Sales Per Share Ttm:0.04
Operating Cash Flow Per Share:-$0.02

Book Value & Capital (2)

Book Value Per Share:$0.11
Cash Per Share:0.01

Dividend Policy (1)

Dividend Payout Ratio:-999.00x
B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.30x
Working Capital Turnover Ttm:0.75x

Receivables Management (2)

Receivables Turnover Ttm:6.51x
Days Sales Outstanding Ttm:56.11

Inventory Management (2)

Inventory Turnover Ttm:2.11x
Days Inventory Outstanding Ttm:173.25

Payables & Cash Cycle (2)

Days Payable Outstanding:175.86
Cash Conversion Cycle:53.50
C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:100.00
Quality Score:40.00

Market Metrics (2)

Beta:0.00x
Volatility Category:unknown
DIVISION IV: INVESTMENT ANALYSIS
A. Value Investment Framework

Owner Earnings Analysis (1)

-$16.61M

Damodaran Growth Analysis (2)

Reinvestment Rate:355.1%
Fundamental Growth Rate (g):-54.2%
B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):16.3%

Other Growth Rates (2)

Gross Profit Growth Rate (Linear):13.5%
Book Value Growth Rate (Linear):-22.5%
C. Company Profile & Context

Corporate Information (6)

Symbol:ZOMDF
Company Name:Zomedica Corp.
Sector:Healthcare
Industry:Pharmaceuticals
Exchange:OTC
Country:United States

Market Classification (3)

Market Cap Category:N/A
Price Category:penny
Volume Category:N/A

Share Structure (3)

Shares Outstanding:979.95M
Shares Outstanding Basic:979.95M
Shares Outstanding Diluted:979.95M

Data Processing Info (3)

Processing Version:v3.0
Last Updated:2026-08-31 19:40:50 UTC
Data Timestamp:2026-08-19T20:08:06.351744
Scroll to Top